Large gap with delayed quotes
Analysis date: 27.06.2025
Global Evaluation
Neutral
Neutral
The stock is classified in the neutral zone since 02.05.2025.
Interest
Strong
Strong
Three stars since 13.06.2025.
Earnings Rev Trend
Positive
Positive
Compared to seven weeks ago, the analysts have raised their earnings per share estimates. This positive trend began 13.05.2025 at a price of 162.27.
Evaluation
Overvalued
Overvalued
Based on its growth potential and our own criteria, we believe the share price is currently moderately overvalued.
MT Tech Trend
Positive
Positive
The forty day technical trend is positive since 02.05.2025.
4wk Rel Perf
25.60%
25.60%
The four-week dividend-adjusted overperformance versus SP500 is 25.60%.
Sensibility
Middle
Middle
The stock has been on the moderate-sensitivity level since 30.05.2025.
Bear Market Factor
Middle
Middle
On average, the stock is likely to decline with the index.
Bad News Factor
Low
Low
When the stock's pressure is specific, the market sanction on average is 2.13%.
Mkt Cap in $bn
590.53
590.53
With a market capitalization >$8bn, ORACLE is considered a large-cap stock.
G/PE Ratio
0.85
0.85
A ratio (Forecasted Growth + Estimated Dividend Yield/ Estimated Price Earnings) below 0.9 indicates that investors must pay a premium for the estimated growth potential:
LT P/E
25.55
25.55
The estimated PE is for the year 2027.
LT Growth
20.88%
20.88%
The annualized growth estimate is for the current year to 2027.
Avg. Nb analysts
34
34
Over the last seven weeks, an average of 34 analysts provided earnings per share estimates.
Dividend Yield
0.93%
0.93%
The twelve month estimated dividend yield represents 23.75% of earnings forecasts.
Beta
136
136
For 1% of index variation, the stock varies on average by 1.36%.
Correlation
0.61
0.61
60.58% of stock movements are explained by index variations.
Value at Risk
50.46
50.46
The value at risk is estimated at USD 50.46. The risk is therefore 24.00%. This value is based on the historical volatility for a medium time period (1 month) with a confidence of 95%.
First Analysis Date
02.01.2002
02.01.2002